These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8624345)

  • 21. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study.
    Inoue Y; Zhang B; Sadamori R; Shirota K; Saku K; Kawarabayashi T
    Menopause; 2008; 15(1):157-63. PubMed ID: 17603392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review.
    Kafonek SD
    Drugs; 1994; 47 Suppl 2():16-24. PubMed ID: 7517830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormones and... many symptoms of menopause means many therapies.
    Levine S; Brink S; Hobson K; Carpenter B; Malrine A
    US News World Rep; 2002 Nov; 133(19):63, 67-70. PubMed ID: 12501477
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL; Blazing MA; Saxena S; Guyton JR
    J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
    Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
    Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [[Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials] ].
    Scheen AJ
    Rev Med Liege; 2000 Sep; 55(9):886-8. PubMed ID: 11105606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The control of cholesterol in the prevention of coronary cardiopathy].
    Vintró IB
    Rev Esp Salud Publica; 1995; 69(6):439-43. PubMed ID: 8789356
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid profile during hormone replacement therapy: effect of different progestins?
    Campagnoli C; Belforte P; Di Sario MM; Lesca L
    Zentralbl Gynakol; 1997; 119 Suppl 2():1-6. PubMed ID: 9361391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone replacement in postmenopausal women with coronary heart disease. Results and clinical consequences from recent studies].
    Schurz RA; Benzer W
    Wien Klin Wochenschr; 1997; 109 Suppl 2():42-5. PubMed ID: 9340923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
    Rosano GM; Mercuro G
    G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
    [No Abstract]   [Full Text] [Related]  

  • 33. Commentary: hormone replacement therapy and coronary heart disease: four lessons.
    Petitti D
    Int J Epidemiol; 2004 Jun; 33(3):461-3. PubMed ID: 15166191
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of 17 beta-estradiol on nitric oxide and ventricular myocardium metabolism].
    Tanaka O
    Nihon Seirigaku Zasshi; 1997; 59(4):155-65. PubMed ID: 9244809
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relationships between intravascular ultrasonographic findings and coronary risk factors in patients with normal coronary angiography].
    Noike H; Hitsumoto T; Sakurai T; Sugiyama Y; Sato S; Iizuka T; Takahashi M; Shimizu K; Nakamura K; Ohsawa H
    J Cardiol; 2005 Jan; 45(1):1-10. PubMed ID: 15700924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 37. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualized hormone-replacement therapy?
    Krauss RM
    N Engl J Med; 2002 Mar; 346(13):1017-8. PubMed ID: 11919312
    [No Abstract]   [Full Text] [Related]  

  • 39. Postmenopausal estrogen therapy and cardiovascular disease.
    Prior JC
    N Engl J Med; 1992 Mar; 326(10):705-6; author reply 707. PubMed ID: 1736112
    [No Abstract]   [Full Text] [Related]  

  • 40. Postmenopausal estrogen therapy and cardiovascular disease.
    Atkins D
    N Engl J Med; 1992 Mar; 326(10):706; author reply 707. PubMed ID: 1736113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.